Interim Chief Executive Officer
Head of Strategy & Growth Initiatives, Lonza AG
Dr. Samuels has 22 years of diverse pharmaceutical experience in large pharma and biotech settings. He has worked in corporate venture, business development, M&A, clinical development, strategy and investor relations. Dr. Samuels is currently Head of Strategy and Growth Initiatives, Biologics Division at Lonza AG, headquartered in Switzerland. He previously served as Vice-President of Global Business Development & Strategy at Teva Pharmaceuticals.
Dr. Samuels received his medical degree from the University of Witwatersrand (South Africa), a postgraduate diploma in Health Economics from Monash University (Australia) and an MBA from the University of New England (Australia).